Denise Dajles Is Remaking Aesthetic Medicine With Skin-Removal Tech

The ellacor system occupies a distinct middle ground between traditional energy-based treatments and invasive surgery. Using hollow needles to physically extract tiny portions of skin, the device triggers a natural regenerative response to tighten and smooth the surface. For Dajles, the primary challenge lies in category creation—educating practitioners who are accustomed to thermal treatments rather than mechanical skin removal. She emphasizes that building trust in a crowded market requires scientific rigor, citing over 10 peer-reviewed clinical studies to validate the technology’s outcomes.

Market demand is being accelerated by the widespread use of GLP-1 drugs, which has left millions of patients with loose skin on their faces and bodies. Dajles notes that physicians are increasingly integrating ellacor into their practices specifically to treat this patient cohort, bypassing the need for traditional surgical intervention. Beyond the technical application, her leadership focuses on listening to real-world clinical feedback rather than relying on internal assumptions. As the company expands into markets including Japan, South Korea, and the UAE, Dajles maintains that disciplined evidence is the only way to sustain long-term growth. She advises other innovators to embrace disruption before they feel fully prepared, warning that without a foundation of hard science, such efforts quickly devolve into market noise.